Does Coronary Flow Trump Coronary Anatomy?  by Gould, K. Lance
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oes Coronary Flow Trump Coronary Anatomy?
. Lance Gould, MD
ouston, Texas
oronary function versus anatomy, flow versus stenosis: which optimizes coronary artery disease (CAD)
anagement? In patients, coronary flow is poorly related to stenosis severity, and revascularization fails to
mprove mortality over medical treatment in randomized trials. Yet percutaneous intervention (PCI)
uided by fractional flow reserve reduces coronary events more than PCI guided by arteriographic
tenosis. These paradoxes are explained by the poor relation between coronary flow reserve (CFR) and
tenosis severity due to diffuse CAD, with surprising clinical implications. Should the concept of anatomi-
ally “critical” coronary stenosis be replaced by the concept of “critical” CFR reduction for managing
AD? (J AmColl Cardiol Img2009;2:1009–23)© 2009by theAmericanCollege of Cardiology Foundationb
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g Ateveral major paradoxes remain unresolved in
he management of coronary artery disease
CAD). The first is that percent stenosis does
ot predict or reliably relate to maximum flow
apacity or coronary flow reserve (CFR) in
uman CAD. The second is that revascular-
zation procedures to improve coronary blood
ow do not reduce coronary events more than
ntense medical treatment in randomized trials.
n contrast to these revascularization trials,
ercutaneous coronary intervention (PCI)
uided by fractional flow reserve (FFR) had
ignificantly fewer follow-up coronary events
han PCI based on angiographic percent ste-
osis. Finally, as an example of the underlying
ssues, a fixed mild stenosis on a clinical arte-
iogram may, in some circumstances, markedly
educe maximum coronary flow and flow re-
erve, reduce FFR, and warrant revasculariza-
ion despite similar mild stenosis not signifi-
antly reducing CFR in precise stenosis of
nimal models.
These paradoxes are so counterintuitive that
hey evoke a wide range of explanations, de-
rom the Weatherhead P.E.T. Center for Preventing and Reversin
t Houston and Memorial Hermann Hospital, Houston, Texas.anuscript received March 31, 2009; revised manuscript received Juneate, or disregard, all of which have elements of
ruth but lack cohesive explanation. This ana-
ytical review addresses these paradoxes with an
xplanation leading to a surprising clinical hy-
othesis: for equal optimal medical manage-
ent, revascularization to improve coronary
ow may reduce coronary events in patients
ith initial severe reduction in absolute maxi-
um coronary flow or CFR, but not in patients
ith adequate flow capacity, independent of
ercent stenosis. In other words, revasculariza-
ion in patients with low coronary flow capacity
ay show mortality benefit over revasculariza-
ion in populations chosen for the revascular-
zation trials based on percent stenosis that is
oorly related to coronary flow capacity.
ild Stenosis Causing Low CFR,
ow FFR, Indicating PCI
he following case illustrates these paradoxes.
he patient in Figure 1 is a 68-year-old man
ith hypertension, past smoking, low high-
ensity lipoprotein (HDL) level, and acute
herosclerosis, University of Texas Medical School10, 2009, accepted June 17, 2009.
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1010yocardial infarction 13 years previously, treated
ith thrombolysis and PCI of the left anterior
escending coronary artery (LAD). Seven years
fter myocardial infarction, rest-dipyridamole
ositron emission tomography (PET) perfusion
maging showed a mild anterior resting defect with
ild stress-induced worsening. Left ventricular
unction was normal. He gained weight, from 198
o 242 lbs, did not maintain a healthy diet, and did
ot exercise. His lipid profile during these years
howed total cholesterol 118 mg/dl, triglycerides
42 mg/dl, low-density lipoprotein (LDL) 59 mg/
l, HDL 31 mg/dl on simvastatin 5 mg, Niaspan
Abbott Laboratories, Abbott Park, Illinois) 2,000
g, and fenofibrate 160 mg daily. Although the
DL level was optimal on drug treatment, the low
DL and unhealthy lifestyle remained uncon-
trolled risk factors for progression.
Routine follow-up PET 6 years after
the first PET showed progression with a
relative stress-induced defect in the mid-
LAD distribution that was 0.65, or only
65% of the activity in adjacent proximal
areas of the heart. There was also a severe
stress-induced defect in the distribution of
a small ramus intermedius or 1st obtuse
marginal branch. Computed tomography
(CT) done for attenuation correction of
PET data showed dense coronary calcifi-
cation of all coronary arteries. Absolute
maximal myocardial perfusion in the mid
to distal LAD distribution was markedly
reduced to 1.2 cc/min/g compared with
2.5 to 3.0 cc/min/g or higher in healthy
young volunteers. The CFR in the distal
LAD distribution was reduced to 1.8
compared with an average of 3.0 in the
est of the heart proximally and compared with 4.0
n healthy young volunteers.
In view of past myocardial infarction and progres-
ive disease, a coronary arteriogram was done showing
oncentric 57% mid-LAD stenosis by automated
uantitative coronary arteriographic analysis (QCA)
nd FFR of 0.65 by pressure wire measurements in
he aorta and distal to the stenosis. A LAD stent was
laced in view of significant progression associated
ith low CFR, low FFR, lowHDL, and uncontrolled
ifestyle despite optimal drug treatment. After stent
lacement, FFR improved to 0.92, indicating im-
rovement but also a residual pressure gradient due to
iffuse disease proximal to the stent.
In precise experimental stenosis models with no
se
ein
und
ing
ry
y
ssioniffuse disease, a 57% stenosis has little effect on CFR, 0s shown below in Figure 2A (1). In this patient,
bsolute perfusion in cc/min/gm showed that the 57%
iameter stenosis was superimposed on moderately
evere diffuse disease, thereby making the cumulative
iffuse and focal disease functionally severe. Relative
ow reserve, or flow-derived FFR, expressed as the
atio of absolute CFR of 1.8 in the distal LAD
istribution to average CFR of 3.0 in the rest of the
eart is 0.6, comparable to the pressure-derived FFR
f 0.65 at coronary arteriography.
ritical Coronary Artery Stenosis and CFR
ome of the basic concepts here were published before
eb- and PDF-based literature and hence are not
widely in mind.” Therefore, original illustrations are
sed to explain these paradoxes, abetted by the adage
hat durability supports validity. The concept of “crit-
cal” coronary artery stenosis was first documented 35
ears ago in animal studies as 85% diameter narrow-
ng, at which resting coronary flow began to fall, and
0% diameter narrowing, at which CFR began to
iminish, illustrated in Figure 2A (1). The experimen-
al canine models used external coronary artery con-
triction with no atherosclerosis or diffuse disease.
Thus, in principle, a 50% to 85% diameter narrow-
ng became the anatomic criterion for classifying
everity of stenosis and the basis for revascularization
rocedures. A single clinical end point of this thresh-
ld range evolved as 70% diameter stenosis, which
emains the anatomic “gold standard” of severity and
uide to procedures. Many experimental studies since
hat time have confirmed the initial observations
elating stenosis dimensions of absolute arterial diam-
ter, length, relative stenosis, the pressure-flow char-
cteristics of coronary stenosis, and CFR (2–11).
natomy Versus Flow in Coronary Atherosclerosis
owever, human studies 25 years ago showed no
elation between CFR and percent stenosis on arte-
iogram (Fig. 2B) (12). Recently, this dissociation in
atients between anatomic and functional severity was
econfirmed by the poor correlation among quantita-
ive percent stenosis on invasive or CT coronary
rteriograms and FFR by pressure wire as a measure of
elative CFR (Fig. 3) (13). The FFR is a validated,
eproducible measure of relative CFR, derived from
ressure measurements in the aorta or proximal and
istal to a localized coronary stenosis at maximum
harmacologic arteriolar vasodilation (13–20). Like
elative CFR (10), it is expressed as a fraction of 1.0
or no flow-limiting stenosis, decreasing toward 0.1 orB B R E V I A T I O N S
N D A C R O N YM S
AD coronary artery disea
FR coronary flow reserve
T computed tomography
FR fractional flow reserve
DL high-density lipoprot
VUS intravascular ultraso
AD left anterior descend
oronary artery
Cx left circumflex corona
rtery
CI percutaneous coronar
ntervention
ET positron emission
omography
PECT single-photon emi.2 for very severe stenosis.
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1011In humans, the dissociation of anatomic and
unctional measures of coronary stenosis severity is
ue to diffuse atherosclerosis and extent of arterial
emodeling. Figure 4A illustrates this simple, but
rofound, concept that underlies most diagnostic,
herapeutic, and interventional management of
AD. However, the broad conceptual and clinical
mplications of this fact are commonly not recog-
ized in cardiovascular medicine, or at least may not
ubstantially influence its practice.
Figure 1. Coronary Function and Anatomic Stenosis Severity
Relative uptake PET perfusion images are scaled by the color bar fr
the next highest, and color gradations from red to yellow, green, a
A generic coronary map based on arteriographic-PET correlations in
to show arterial distributions. The arteriogram shows quantitative c
DS  diameter stenosis; FFR  fractional ﬂow reserve; LAD  left a
obtuse marginal branch; OM2  second obtuse marginal branch; P
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Figure 2. Experimental Versus Clinical Stenosis Severity
(A) Coronary ﬂow reserve versus arteriographic percent diameter st
Gould et al. (1). (B) Coronary ﬂow reserve in open-chest humans at
or open circles or squares indicate different coronary arteries. Repr
artery; other abbreviations as in Figure 1.In Figure 4A for an otherwise normal artery,
rawn to scale, an arteriographic 63% diameter
onstriction mildly reduces CFR to 3.5 from the
ormal of 4.0 that characterizes young volunteers
ithout risk factors. An arteriographic 87% diam-
ter constriction in a coronary artery reduces CFR
o 1.0, i.e., eliminates capacity for increasing flow,
n the absence of diffuse disease (1). Now consider
different artery with 38% diameter diffuse narrow-
ng without arterial remodeling and no segmental
0% to 100% for maximum relative uptake (white), with red being
blue indicating progressively lower relative myocardial perfusion.
r 1,000 patients is superimposed on the relative perfusion images
ary arteriographic analysis (QCA). CFR  coronary ﬂow reserve;
ior descending coronary artery; LCx  left circumﬂex; OM1  1st
positron emission tomography; RI  ramus intermedius.
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sis in canine experimental model. Adapted, with permission, from
ass surgery versus arteriographic percent diameter stenosis. Solid
ced, with permission, from White et al. (12). RCA  right coronaryom
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1012tenosis. This modest, diffuse narrowing along the
hole length of the artery has a dramatic fluid
ynamic effect, reducing CFR to 1.4 (11). The
ame diffuse narrowing plus an arteriographic 60%
iameter stenosis without remodeling reduces CFR
o 1.0, essentially eliminating the capacity for in-
reasing flow.
natomy Versus FlowWith
oronary Artery Remodeling
rterial remodeling markedly alters the anatomic-
unctional measures of severity of both segmental and
iffuse disease. With remodeling, despite comparable
iffuse disease and arteriographic stenosis, CFR is
nly mildly reduced to 3.5 in this example. For each of
hese cases, intravascular ultrasound (IVUS) would
easure percent stenosis of the lumen compared with
he elastic external membrane of the artery, thereby
seeing” diffuse disease and more severe stenosis not
pparent on the arteriogram. However, for diffuse
isease with no “normal” segments, IVUS does not
easure the extent of remodeling or account for the
umulative effect of narrowing length on flow.
For each of these schematic examples, Figure 4B
Diameter Stenosis by QCA, %
FF
R
0.5
0.75
0.80
1.0
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Diameter Stenosis by CCA, %
FF
R
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<50% >50%
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Figure 3. Coronary Function Versus Stenosis Anatomy
Fractional ﬂow reserve (FFR) by pressure wire versus percent diame
tive coronary computed tomography (QCT) angiogram, by visually e
nary CT angiography (CTCA) for 50% diameter stenosis threshold. Rlots anatomic percent stenosis by arteriogram and (y IVUS compared with CFR. It is a scattergram,
ssentially the same as observed in patients in
igure 2B, explaining why anatomic measures of
tenosis, even by precise dimensions of IVUS, fail to
orrelate with maximum flow or CFR in humans.
epending on the extent of diffuse disease and of
emodeling, anatomic measures of stenosis severity
y either arteriogram or IVUS do not indicate the
unctional severity of stenosis or flow capacity
espite their role in documenting regression or
rogression of coronary atherosclerosis. In reality,
he coronary arteries in CAD have a heterogeneous
ix of all the combinations illustrated in the sche-
atic of Figure 4A in any single artery and/or
mong all the coronary arteries of any individual,
hereby making the relation between percent steno-
is by either arteriogram or IVUS and coronary flow
apacity even more unpredictable than illustrated by
ny one of the alternative schemas in Figure 4A.
The challenge to current anatomically driven
ardiology is even more profound in view of the
ocumented errors of visually interpreted invasive
rteriograms, and inadequacy of even quantitative
T angiography to differentiate among intermedi-
te stenosis of 30% to 75% diameter stenosis
Diameter Stenosis by QCT, %
0.5
0.75
0.80
1.0
10 30 50 70 90
Diameter Stenosis by CTCA, %
0.5
0.75
0.80
1.0
<50% >50%
tenosis by quantitative coronary arteriogram (QCA), by quantita-
ated coronary arteriogram (CCA), and by visually estimated coro-
duced, with permission, from Meijboom et al. (13).008
ter s
stim13,21).
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1013Although it is well established in the literature
nd widely accepted intellectually, cardiologists
ommonly disbelieve that their “eyeball scale” is so
ifferent from actual or objectively measured sever-
ty. Figure 5 shows cine views of precisely known
imensions and percent diameter stenosis of a
-mm model “artery” filled with contrast medium
mmersed in water with no motion. The 0.5-mm
umen of the 83% stenosis is mottled due to the
imited resolution of even the invasive arteriogram.
so-called 90% diameter stenosis of a 3-mm artery
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Figure 4. Coronary Function Versus Anatomy With Diffuse Coro
(A) Schematic illustrating limitations of anatomic measures of steno
due to diffuse disease with and without remodeling compared to c
scatter plot of coronary ﬂow reserve (CFR) versus percent diameter
low circles). The numbers beside each point of the scatter gram cill not have a visible lumen on cine, and fluid tynamic analysis requires over 400 mm Hg pressure
or forward contrast flow to fill the artery.
natomic Stenosis MayMislead Both for and
gainst Revascularization Procedures
n the absence of diffuse disease, the 63% diameter
tenosis in Figure 4 would have a CFR of 3.4 as
hown in Figure 2A. However, visual reading would
ikely be of greater severity leading to PCI that is
ot necessary, given the capacity to increase flow 3
No stenosis
87% stenosis
63% stenosis
Diffuse   no stenosis
IVUS 38%
Diffuse + 60% Artgm
IVUS 75%
Diffuse + 62% Artgm
IVUS 75% & adaptive
remodeling
CFR = 4.0
CFR = 1.0
CFR = 3.4
CFR = 1.4
CFR = 1.0
CFR = 3.5
5 5 2
66
3
60 80 100
Stenosis
y Artery Disease and Remodeling
everity by arteriogram (Artgm) or intravascular ultrasound (IVUS)
ary ﬂow reserve. (B) For the schematic arteries illustrated in A, a
osis (%DS) by arteriogram (brown diamonds) and by IVUS (yel-
spond to the numbered schematic examples of A.ter 
nar
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stenimes baseline. However, moderate diffuse disease
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1014ithout remodeling and a 60% stenosis would
everely reduce CFR to 1.0 and cause ischemia such
hat PCI might be indicated to improve flow up to
he limit imposed by the diffuse disease. On the
ther hand, severe diffuse disease might limit flow
o severely that doing PCI on the stenosis would
ot improve flow. Only FFR or quantitative PET
erfusion imaging can sort out the contribution of
he localized stenosis versus the diffuse disease as
llustrated in the patient examples below.
natomy Versus FFR: Clinical Outcomes
or deciding revascularization procedures, the clin-
cal advantage of functional measures of stenosis
everity as opposed to anatomic measures is well
stablished. In patients with greater than 50%
iameter stenosis visually on invasive coronary ar-
eriogram, those randomized to FFR-guided PCI
or FFR 0.8 had fewer PCI procedures and better
linical outcomes than patients randomized to PCI
ased on visual judgments of arteriographic severity
Fig. 6A) (13,17–19). Furthermore, in many ran-
eference Standard for Visual Percent Stenosis
s of a precise stenosis phantom consisting of contras-ﬁlled chan-
lastic block immersed in water without motion, as a visual “train-
nce. Abbreviation as in Figure 4.omized trials of patients with stable CAD and ntenosis arteriographically suitable for revasculariza-
ion, those undergoing revascularization procedures
ad no benefit on mortality or coronary events over
edical management, illustrated for PCI in the
ost recent of these trials in Figure 6B (22). At the
- to 5- year follow-up, there was also no difference
n angina between the PCI and medically treated
roups.
These studies indicate that anatomic measures of
oronary stenosis are suboptimal guides to the man-
gement of CAD from every viewpoint—physiology,
echnology, clinical management, outcomes, risks, and
osts—yet remain the central guide to current cardio-
ascular practice. Based on current data, FFR is the
nvasive definitive physiologic gold standard for as-
essing stenosis severity as the basis for revasculariza-
ion procedures that reduces unnecessary procedures,
ith better clinical outcomes than revascularization
ecisions based on anatomic severity. Quantitative
ET perfusion imaging is the noninvasive definitive
old standard for assessing physiologic stenosis sever-
ty by absolute maximal myocardial perfusion in cc/
in/g and CFR.
ixed Anatomic Viewpoint?
hat explains this anatomic focus of cardiologic
ractice against substantial opposing scientific data?
nvasive cardiologists provide a verbatim answer as
ollows: “Although cardiologists might believe they
re benefiting their stable patients with CAD by
erforming PCI, this belief appears to be based on
motional and psychological factors rather than on
vidence of clinical benefit.” “The only thing that
ould really change is if there had been an imaging
tudy—and it would have changed it, not by how
ou responded to the catheterization, but by not
oing the catheterization at all” (23).
This conclusion by an invasive cardiologist from
peer-reviewed published survey on use of PCI in
table CAD may help explain why FFR is seldom
easured at coronary arteriography prior to PCI in
he U.S. despite hard data on its benefits as the basis
or these procedures. The same anatomic viewpoint
ay also help explain why, despite guidelines of the
merican College of Cardiology recommending
tress testing before PCI, only 45% of patients
ndergoing elective PCI for stable CAD have a
rior stress test, with great geographic variation in
he U.S. (24). The literature shows the following
acts: 1) systematic visual overestimation of stenosis
everity compared with objective quantitative coro-Figure 5. R
Cine image
nels in a pary arteriographic analysis; 2) in the U.S., 55% of
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1015lective PCI procedures do not have a prior stress
est despite guidelines of the American College of
ardiology; 3) revascularization procedures have no
enefit over medical treatment for coronary events
r mortality in randomized trials; and 4) FFR is not
idely used in the U.S. as a basis for doing PCI or
ot despite randomized trials on its efficacy for
electing patients for PCI.
Emphasizing these facts does not imply that cardi-
logists are making conscious decisions to do proce-
ures that are recognized as unnecessary. Rather, the
mplication is that the procedures are done in the
ntuitive belief that revascularization of anatomic ste-
osis generally improves coronary flow despite contra-
ening data that remain inadequately explained. This
nalytical review provides an integrated concept ex-
laining these paradoxes and associated skepticism
bout the “no added benefit data” that are intuitively
ontrary to the envisioned benefit of improving coro-
ary flow by revascularization procedures.
The oculoanatomic reflex, invasive technology,
nd contravening coronary physiology, noninvasive
echnology, and outcomes of medical treatment, all
ood medical science, are here to stay but need
etter integration or balance.
A potential solution to these conflicting view-
oints is outlined in this integrated analysis: mea-
ure resting and maximal absolute myocardial per-
usion in cc/min/g and CFR as the primary guide to
nvasive procedures, revascularization, and for fol-
owing changes in CAD using available technology,
aximal pharmacologic treatment, and lifestyle in-
ervention, all of which are already proven effective.
A
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Figure 6. Coronary Function Versus Stenosis and Clinical Outco
(A) Randomized trial of fractional ﬂow reserve (FFR)-guided percuta
guided PCI in 1,008 patients. Reproduced, with permission, from To
and a signiﬁcantly lower composite end point of death, nonfatal m
(B) Randomized trial of PCI compared with medical treatment in 2,2
riogram, showing no mortality advantage of PCI over medical treatmf a stenosis does not markedly limit regional Cyocardial perfusion or CFR, an invasive arterio-
ram and revascularization procedure will not likely
e beneficial. For residual uncertainty about steno-
is severity, FFR measured by pressure wire at the
ime of the coronary arteriogram provides reliable
nvasive confirmation for proceeding or pulling out
ithout PCI.
bsolute Myocardial Perfusion in
c/min/g and CFR by PET
lthough coronary flow is a major focus of the
ardiology profession that justifies procedures based
n improving it, few cardiologists quantify myocardial
erfusion or measure CFR or have ever measured it,
r even understand how to use the information if
btained, here addressed. For several years, this lab has
outinely quantified myocardial perfusion in cc/min/g
nd CFR in all patients undergoing diagnostic cardiac
tress perfusion PET using rubidium-82. For this
iscussion, CFR is used interchangeably with myo-
ardial perfusion reserve. Absolute perfusion is deter-
ined using our “simple” method particularly suitable
or rubidium-82, validated experimentally with mini-
al methodologic variability (25,26), and semiauto-
ated for routine clinical application. Attenuation-
mission misregistration is routinely checked and
orrected for every patient using cine CT attenuation
orrection that accounts for breathing motion (27–
9). Our PET perfusion images are displayed as if
ooking at 90° quadrants of the heart rotating through
60°, with a superimposed generalized arterial map as
n the illustrations below for the various categories of
B 2007
Years
No. at Risk
Medical
 Therapy 1138 1017 959 834 638 408 192 30
PCI 1149 1013 952 833 637 417 200 35
PCI
Medical Therapy
Hazard Ratio, 1.05; 95% CI (0.87-1.27);
P=0.62
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us coronary intervention (PCI) compared to arteriographically
et al. (18). The FFR-guided group had fewer invasive procedures
rdial infarction, and repeat revascularization at 1 year (p  0.02).
patients with coronary stenosis that was suitable for PCI by arte-
t. Reproduced, with permission, from Boden et al. (22).60
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1016Figure 7 illustrates a common clinical problem of
ssessing coronary calcification. The patient is a
5-year-old man with hypertension, hypercholes-
erolemia, atypical chest pain, dense coronary cal-
ification with a calcium score 4,000, and a
oronary CT angiogram reported as the following
ercent diameter stenosis of the left main 50%,
AD 75% to 80%, left circumflex (LCx) 70% to
0%, and right coronary artery 50%. A coronary
rteriogram and bypass surgery were recommended,
eading him to request a PET scan and second
pinion. His rest-dipyridamole PET perfusion im-
ges, Figure 7A, show resting heterogeneity and
mall, mild-to-moderate, stress-induced perfusion
efects in the basal left lateral distribution of a
econd obtuse marginal (OM2) branch (white ar-
ow) and in the distal inferoapical distribution
white arrow) typical of a LAD wrapping around
he apex. Although there are no large severe perfu-
ion defects, “balanced” coronary disease might fail
o reveal severe, localized, relative perfusion defects.
However, Figure 7B shows good absolute myo-
ardial perfusion and CFR. The maximal perfusion
ith dipyridamole stress averaged 2.9 cc/min/g for
he whole heart, and CFR averaged 3.7, comparable
o 4.0 for young healthy volunteers. The septal
istribution has a CFR of 4.1, indicating no signif-
Figure 7. Quantitative PET for Stenosis Severity and Determinin
(A) Topographic 3-D displays of PET relative perfusion in 90° quadr
scaled as for Figure 1. (B) Absolute myocardial perfusion in cc/min/
for 4  4 pixel sample volumes throughout the left ventricle. The q
large square grid lines for semiautomated processing into cc/min/g
ues, the apical region and the region of the membranous septum a
average quadrant values. ANT  anterior; INF  inferior; LAT  latecant left main stenosis since myocardial perfusion nan increase 4 times baseline, comparable to young
ealthy volunteers. In the LCx distribution, CFR is
.7, and in the LAD distribution, CFR is 3.4,
onsistent with mild narrowing. In the small, mild-
o-moderate, basal-lateral, and distal inferoapical
elative stress-induced defects, maximum absolute
erfusion is 1.8 cc/min/g and CFR is 2.7. Even in
hese small “worst” regions, maximum perfusion is
uite good, far above ischemic levels, with flow
ncreasing during stress to 270% of baseline flows.
he regions of resting flow heterogeneity that
mprove with dipyridamole stress are associated
ith coronary atherosclerosis (30).
The quantitative PET findings explain why this
atient can do hard physical exertion without an-
ina, including heavy weight lifting that caused
ome nonexertional musculoskeletal pain, but not
ngina. He has diffuse, severe, calcific, nonobstruc-
ive coronary atherosclerosis, but does not have
linically significant flow-limiting stenosis that re-
uires invasive coronary arteriogram or revascular-
zation. The reported stenosis severity on CT an-
iogram is not accurate and fails to indicate
oronary flow capacity. The CT spatial resolution is
ot adequate for determining severity (21) that was
verestimated, as also documented for invasive ar-
eriograms. Even with precise high-resolution ste-
rocedures
from left lateral, to inferior, septal (right), and anterior views,
rest, with dipyridamole stress and CFR as scaled by the color bar
titative image is displayed in square quadrants delineated by the
FR. To avoid partial volume errors biasing average quadrant val-
e the upper and lower horizontal grid lines are excluded from
SEP  septal; other abbreviations as in Figure 1.g P
ants
g at
uan
or C
bovosis measurements, anatomic severity is not reli-
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1017bly related to maximal perfusion or CFR due to
iffuse disease and varying degrees of arterial re-
odeling, as shown in Figure 4A.
Figure 8 illustrates what absolute myocardial
erfusion and CFR “tell” us in 3 different patients
ith severe CAD. Except for the single resting
aseline inferior views shown in Figure 8A, all other
uadrant views of the resting relative perfusion
mages were normal for all 3 patients and not shown
s redundant. Patient #1 with hyperlipidemia had
n inferior myocardial infarction at age 29 years
ith a residual inferior scar (blue) on the resting
mage. Patients #2 and #3 had no myocardial scar
n the resting standard relative uptake images. The
tandard relative stress uptake images in Figure 8A
re all similar, with a severe inferior perfusion defect
n stress images and mild-to-moderate stress-
nduced perfusion defects elsewhere.
However, myocardial perfusion in cc/min/g dur-
ng dipyridamole stress for each of these patients in
igure 8B reveals dramatically diverse extent of
AD. For Patient #1, CFR in noninfarct regions is
airly good, ranging from 2.9 to 3.2, indicating only
ild flow-limiting narrowing other than the oc-
luded posterior descending coronary artery (PDA)
ausing the inferior scar. The CFR in the scar is 1.0,
ndicating no change in perfusion with dipyridam-
le stress other than modest, small border zone
reas. For Patient #2, CFR is severely, diffusely
educed with severe inferior myocardial steal (CFR
.4), indicating collaterals to viable inferior myocar-
ium (no resting defect) in the distribution of an
Figure 8. Quantitative PET for Assessing Severe Stenosis
(A) PET relative perfusion images in 3 different patients with severe
views shown for each patient, all other quadrant views of resting re
normal for all 3 patients. (B) For each of the same 3 patients, CFR t
heart and average quadrant values are shown for each quadrant. Accluded PDA. The severity of 3-vessel disease feducing CFR throughout and the myocardial steal
ndicate that the arteries supplying the collaterals
re all severely diseased.
For Patient #3, CFR ranges from 2.5 to 4.4 in
roximal LCx and proximal LAD distributions,
apering to 1.5 to 2.0 in mid to distal arterial
istributions. This longitudinal base-to-apex gradi-
nt or tapering of CFR is characteristic of diffuse
arrowing (31,32). An obtuse marginal branch
upplies part of the mid inferolateral region with a
FR of 3.0. The CFR of 0.9 in basal inferior and
nferolateral distributions indicates myocardial steal
ssociated with collaterals to viable myocardium (no
esting scar) beyond an occluded PDA and oc-
luded distal LCx. As part of our clinical studies of
bsolute myocardial perfusion, all 3 patients had
oronary arteriograms that confirmed these find-
ngs. Patient #1 needed no revascularization proce-
ure as indicated by quantitative PET. For Patient
2, arteriogram showed diffuse and segmental dis-
ase for which he refused bypass surgery for 2 years,
ut with progressive angina, then had successful
ypass. Patient #3 did not show anatomy suitable
or revascularization due to severe diffuse disease,
ith collateralized occluded arteries as predicted by
ET, but became asymptomatic on vigorous life-
tyle and medical treatment.
Figure 9 illustrates what absolute myocardial
erfusion and CFR tell us for 3 different patients
ith positive single-photon emission computed to-
ography (SPECT) stress tests and/or chest pain
ho sought a second opinion after recommendation
onary artery disease. Except for the single resting baseline inferior
e uptake images (lateral, anterior, and septal quadrants) were
ghout the left ventricle is shown. Average CFR for the whole
viations as in Figure 1.cor
lativ
hrouor an invasive procedure. Again, only the resting
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1018orst relative perfusion views are shown, other
esting views being normal and not shown as
edundant. The stress relative perfusion images in
igure 9A are all similar with only mild-to-
oderate, small, scattered stress-induced perfusion
efects. However, perfusion in cc/min/g during
ipyridamole stress for each of these patients in
igure 9B also reveals dramatically diverse extent of
AD. Patient A has good CFR of 3.5 throughout
he left ventricle and does not need any procedures
ince the SPECT abnormality was an attenuation
rtifact. Patient B shows diffuse, uniform, moderate
eduction of CFR with no significant regional
tress-induced defects, consistent with diffuse
mall-vessel disease associated with diffuse coronary
alcification and hypertension in this asymptomatic
atient for which an arteriogram is not indicated.
n the relative uptake images of Figure 9A, Patient
has the most severe localized basal inferior and
nferoseptal defect of these 3 patients, but has
emarkable CFR, averaging 5.0 throughout the left
entricle. In the moderately severe relative stress-
nduced defects of the relative PET images in
igure 9A, CFR is adequate at 2.9, and an arterio-
ram is not indicated since myocardial perfusion
an increase by nearly 3 times baseline flow in the
orst regional relative stress-induced defect.
hat DoesMyocardial Perfusion Quantified in
c/min/g and CFR Tell Us Clinically?
hese examples show that absolute myocardial
erfusion and CFR reveal insights into the coronary
Figure 9. Quantitative PET for Assessing Mild Stenosis
(A) PET relative perfusion images in 3 different patients with less se
single resting baseline inferior views, all other quadrant views of re
nary ﬂow reserve for each of the same 3 patients. Abbreviation as iirculation that far surpass even high-quality,rtifact-free, relative PET perfusion images. Clini-
ally interpreting or “reading” absolute perfusion
nd CFR is substantially different from interpreting
elative uptake PET or SPECT images, and more
omplex, here summarized based on my experience
n the first 1,000 cases:
. The numbers in cc/min/gm and CFR values are
the critical end points that can be scaled by a
color bar, but colors are only a visual aid to
“seeing” the critical absolute numbers.
. Classifying absolute perfusion and CFR as nor-
mal or abnormal for a given patient is nearly
meaningless clinically because many people over
40 to 50 years of age have some nonobstructive
coronary atherosclerosis or some other cause of
reduced CFR compared with healthy young
volunteers. Therefore, the essence of clinically
interpreting absolute perfusion and CFR is
“how bad” CFR or absolute maximal flow is,
not whether they are “normal” or not. Clinical
interpretation of the severity of impaired perfu-
sion is the essential guide to invasive proce-
dures, not the binary normal–abnormal catego-
rization now used for relative perfusion images
in which relative defects require arteriographic
assessment or confirmation. Thus, the guide to
invasive procedures is to “read the worst quad-
rant values of maximum flow and CFR” of the
left ventricle corresponding to each major cor-
onary artery.
. Both maximum absolute perfusion in cc/
min/gm and/or CFR are separately and inde-
stress-induced relative perfusion abnormalities. Except for the
relative uptake images were normal for all 3 patients. (B) Coro-
gure 1.vere
stingpendently important for clinical purposes. Rest-
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1019ing perfusion may be increased at higher heart
rates or blood pressure, thereby reducing CFR
despite high maximum perfusion values. The
argument of CFR or maximum absolute perfu-
sion as “better” than the other fails to recognize
the complexity of coronary physiology in which
either may be important depending on resting
perfusion and diffuse disease as addressed in the
next section.
. Regional maximal stress-induced perfusion in
cc/min/g, coronary flow reserve, and relative
perfusion images are all necessary for complete
understanding of segmental and diffuse CAD as
the basis for invasive procedures. Diffusely re-
duced maximum perfusion or CFR with no
focal worse stress-induced defect indicates dif-
fuse disease without sufficient additional local-
ized stenosis that revascularization would ben-
efit. With both diffusely reduced absolute
maximum perfusion or CFR and regional worse
defects, the relative importance and potential
value of revascularization is judged from the
regional absolute maximal cc/min/gm and of
the regional values versus other areas.
. In our experience, the threshold for clinically
significant flow-limiting stenosis that might
justify an invasive procedure requires an abso-
lute maximum perfusion below 1.0 to 1.2 cc/
min/g after dipyridamole stress and/or CFR of
1.5 to 1.7 or lower and a corresponding regional
stress-induced abnormality on relative perfusion
images, or other regions with substantially bet-
ter absolute perfusion/CFR, indicating severe
segmental disease in addition to whatever dif-
fuse narrowing is present. These limits are
subject to modification with more data and
experience, probably toward lower flows as the
threshold for intervention. Of course, all quan-
tification needs to be viewed from a clinical
perspective, including symptoms, response to
medical treatment, comorbidities, physiologic–
clinical judgment, and ongoing evolving data on
management of CAD.
. Myocardial steal associated with collateralization
beyond an occluded coronary artery is valuable
clinical information that can be assessed only by
measuring absolute perfusion and CFR. A CFR
of 1.0 indicates a fall in perfusion during stress
to below resting levels, or myocardial steal. Al-
though the term steal is widely used, it is a
misnomer in a sense because blood is not pulled
from one myocardial region into another region.
Rather, during dipyridamole-induced high flow, vthe pressure drop along a diseased artery supplying
the collaterals decreases the perfusion pressure at
the collateral source, thereby decreasing collateral
flow (11).
. Absolute perfusion and CFR provide essential
physiologic information about isolated stenosis
severity, multiple stenosis, diffuse CAD, or com-
bined multiple stenosis and diffuse disease that
characterizes most CAD. If the coronary arterio-
gram is truly normal without stenosis and without
diffusely small arteries, then absolute perfusion
and CFR may also quantify small-vessel disease.
hich Is Best: MaximumMyocardial Perfusion
n cc/min/g or CFR?
n many patients, maximum myocardial perfusion
ay be severely reduced to the 1.0 to 1.2 cc/min/gm
ange. However, with beta-blockade and good risk
actor control, heart rate of 45 to 50 beats/min, and
ystolic blood pressure of 100 to 110 mm Hg, the
esting myocardial perfusion is commonly as low as
.4 cc/min/g with CFR of 2.5 to 3.0 and no
xertional angina. Therefore, continued medical
anagement is a valid option to revascularization
ince the coronary arteries retain the capacity for
ncreasing flow to meet increased demand within
his overall lower reset demand–supply balance.
owever, if the resting perfusion were 0.8 to 0.9
c/min/g with the same maximum perfusion of 1.0
o 1.2 cc/min/g, as in a diabetic patient who does
ot feel cardiac pain, then CFR is profoundly
mpaired and revascularization is indicated.
Another reason for considering CFR as well as
aximum perfusion alone is technical, related to the
ethodology of determining absolute perfusion. De-
ermining the arterial input function of the radionu-
lide may be somewhat difficult. If the imaged arterial
nput were lower than the real value, the absolute
erfusion would be too high and would underestimate
ow restriction both regionally and throughout the
eart at rest and stress, thereby underestimating dis-
ase severity. However, to some extent, partially, the
tress–rest ratio or CFR would be somewhat less
ffected by a systematic error in arterial input. There-
ore, a low regional CFR with a big severe relative
efect, with ECG changes or exertional angina, but
aximum absolute perfusion of 2.5 to 3.0 cc/min/g,
ould make one suspect an error in the arterial input
unction. Hence, CFR may provide confirming infor-
ation important for major decisions about people’s
ives. Finally, CFR based on absolute perfusion pro-
ides some comparison to other measures of severity
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1020uch as the relative uptake images and invasive FFR
etermined from pressure measurements as confirm-
ng data.
FR, Relative CFR, Absolute CFR, and
erfusion Images
ressure-derived FFR is equivalent to relative CFR,
.e., the ratio of maximum flow in the stenotic artery
o maximum flow of the same nonstenotic artery
13–20) expressed as a fraction of 1. FFR derived
rom pressures just proximal and distal to a specific
tenosis does not account for and is not affected by
iffuse disease. However, FFR derived from pres-
ures in the aorta and just distal to the stenosis
eflects the combined effects of both the stenosis
nd diffuse disease proximal to the stenosis.
Rephrasing the same paradox above gives an
dditional insight into the diffuse disease issue. In
ealthy young volunteers, CFR is typically 4.0 or
igher by quantitative PET in our lab. An FFR of
.75 or lower has been associated with clinical
schemia and indication for PCI. However, 0.75
imes a normal CFR of 4.0 indicates a remaining
ow reserve of 3.0 that never causes ischemia in our
xperience and is higher than many asymptomatic
eople over 40 years of age without known CAD.
herefore, why does an FFR threshold of 0.75
ndicate ischemia in clinical trials of its use? The
nswer to this version of the paradox is the same:
iffuse disease in addition to whatever stenosis is on
he arteriogram. The FFR studies were done on
opulations at risk for CAD due to risk factors and
igh prevalence of diffuse disease. Consequently,
heir absolute CFR is not 4.0, but averages 2.0 to
.5 in our experience, so that the FFR threshold of
.75 corresponds to an absolute CFR of 0.75 times
.2, or 1.7, which is approximately what we observe
n untreated patients with mild exertional angina.
Relative perfusion images (standard radionuclide
ptake images) also show relative perfusion defects
n the stenotic region compared with an adjacent
egion expressed as a ratio or fraction of 1, similar to
ressure FFR and relative CFR determined from
bsolute perfusion. However, if the adjacent artery
upplying the adjacent myocardial region is also
tenotic, the relative defect severity on relative
erfusion images is reduced, whereas pressure FFR
nd relative CFR by absolute perfusion in 1 coro-
ary artery do not depend on the status of the
djacent coronary artery. vechnical Issues in Quantitative Cardiac
ET Perfusion Imaging
tandard cardiac PET-CT protocols and software are
ssociated with misregistration errors causing signifi-
ant artifactual abnormalities in 20% to 40% of pa-
ients (27–29). Therefore, we developed software for
ine CT attenuation correction by acquiring continu-
us low-dose CT scans during 2 breathing cycles that
etter matches emission data without added radiation
xposure (28,29). In principle, a 3-rod rotating trans-
ission system for attenuation correction would min-
mize misregistration problems of PET-CT, reduce
adiation dose, cost less, and be comparably fast.
For radionuclides with complex kinetics, ade-
uate curve fitting of mathematical low models
equires frequent brief images that are count poor
ith high noise and limited clinical value. The
inetic model for rubidium-82, a potassium analog,
s “simple” since cellular trapping of potassium and
ubidium is nonlinearly proportional to flow with
o exiting from the myocardial cell during imaging.
s validated in Figure 10, the “simple” rubidium
ow model accounts for flow-dependent extraction
25,26,33) with a single 2-min arterial input image
nd a single 5-min myocardial uptake image,
hereby providing high-quality, high-count, low-
oise images from which absolute perfusion is
imply and reproducibly determined for routine
emiautomated clinical imaging. N-13 ammonia
as also proven to be an excellent quantitative
linical radionuclide.
linical Impact of Quantitative Myocardial
ET Perfusion Imaging
he PET-guided management of coronary athero-
clerosis integrated with intense lifestyle and vigor-
us pharmacologic treatment reduce coronary
vents and invasive procedures by 80% over 5-year
ollow-up (Fig. 11) (34). Serial changes in PET
erfusion images, illustrated in Figure 12A, show
esponse to treatment, predict outcomes, and pro-
ide insights into progression/regression of the
orst baseline stenosis as well as new lesions, or
revention of new lesions, at follow-up (34,35),
llustrated in Figure 12B. The left ventricular quad-
ant with the maximal change from baseline to
ollow-up PET, for either better or worse, was
ifferent from the baseline worst quadrant in 77% of
09 patients in this 5-year study; the maximum
hange quadrant coincided with the worst baseline
uadrant in only 23% of patients (35). This obser-
ation indicates that for most patients, the greatest
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1021erfusion changes over 5-year follow-up were seen
n regions other than the baseline worst quadrant
orresponding to the most severe stenosis, again an
natomic–functional dichotomy.
The economic impact of PET-guided manage-
ent in clinical practice has also been demonstrated
ith reduced invasive procedures, lowered overall
osts, and good outcomes compared with the stan-
ard anatomic diagnostic treatment paradigm (36).
lthough providing powerful clinical insights,
uantitative cardiac PET perfusion imaging re-
uires substantial care, commitment, specific PET
raining, knowledge of the technology and of cor-
nary physiology, and physiologically oriented clin-
cal judgment. The physiologic data are sufficiently
omplex to need integration into clinical decisions
y a thought process beyond binary anatomic cate-
orization of “critical” coronary artery stenosis driv-
ng current cardiovascular practice.
onclusions
ased on an extensive literature, the concept of
natomically “critical” coronary stenosis should be
eplaced by the concept of “critical” reduction of
ow capacity initially by noninvasive quantitative
ET perfusion imaging as the optimal guide for
ecisions on invasive procedures, for medical man-
gement, and for following changes in coronary
therosclerosis before clinical events, with invasive
ressure-derived FFR as needed for any remaining
ncertainty about stenosis severity. Randomized
rials of revascularization procedures in patients
Microsphere Flow (ml/min/g)
A
FRb = 0.16(± 0.06) + 0.91(± 0.02)Fµ
n = 106
r = 0.97
p < 0.001
R
ub
id
iu
m
 F
lo
w
 (m
l/m
in/
g)
0
1
2
3
4
7
8
9
5
6
0 1 2 3 4 5 6 7 8
Figure 10. Experimental Veriﬁcation of Rubidium-82 for Measur
(A) Initial validation of absolute myocardial perfusion using rubidium
microspheres. Reproduced, with permission, from Goldstein et al. (3
using the “simple ﬂow model” compared with the more complex co
tion with CFR measured by ﬂow meter. Reproduced, with permissioelected for severe reduction in maximum absoluteyocardial perfusion and CFR as compared with
atients selected for revascularization based on per-
ent stenosis, which is poorly related to CFR, might
nally fulfill the intuitive expectation that improv-
ng coronary blood flow benefits clinical outcomes.
iven the prevalent overestimation of stenosis se-
erity on arteriogram, the anatomic severity neces-
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measured by epicardial radiation detectors compared with
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1022ary to reduce substantially maximal myocardial
erfusion or CFR, and extent of diffuse disease,
atient selection based on quantitative PET perfu-
ion imaging would also likely reduce the numbers
Figure 12. PET for Following Changes in CAD
(A) Single views of stress PET relative perfusion images at baseline
regression of coronary artery stenosis in the single view with a perf
Schematic of stress PET images at baseline compared with follow-u
from Sdringola et al. (35). Abbreviations as in Figures 1 and 3.Am J Cardiol 1978;41:267–78. Coll Cardiol 1990;eprint requests and correspondence: Dr. K. Lance
ould, The Weatherhead P.E.T. Center, University of
exas Medical School, 6431 Fannin Street, Room
.256MSB, Houston, Texas 77030. E-mail: k.lance.
follow-up of 2 different patients, illustrating progression and
n abnormality, other normal views not shown as redundant. (B)
T in various quadrant pairings. Reproduced, with permission,of procedures by optimal patient selection. gould@uth.tmc.edu.1
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